Mu‐Hung Tsai
About
In The Last Decade
Mu‐Hung Tsai
16 papers receiving 235 citations
Peers
Comparison fields: 5 of 47
- Otorhinolaryngology 111
- Oncology 96
- Surgery 90
- Pulmonary and Respiratory Medicine 66
- Molecular Biology 28
Countries citing papers authored by Mu‐Hung Tsai
This map shows the geographic impact of Mu‐Hung Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu‐Hung Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu‐Hung Tsai more than expected).
Fields of papers citing papers by Mu‐Hung Tsai
This network shows the impact of papers produced by Mu‐Hung Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu‐Hung Tsai. The network helps show where Mu‐Hung Tsai may publish in the future.
Co-authorship network of co-authors of Mu‐Hung Tsai
This figure shows the co-authorship network connecting the top 25 collaborators of Mu‐Hung Tsai. A scholar is included among the top collaborators of Mu‐Hung Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mu‐Hung Tsai. Mu‐Hung Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 3 | |
| 10 | 14 | |
| 11 | 5 | |
| 12 | 5 | |
| 13 | Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies. | 16 |
| 14 | 5 | |
| 15 | 7 | |
| 16 | 99 | |
| 17 | 36 | |
| 18 | 0 | |
| 19 | 23 | |
| 20 | 13 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.